WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085960) BACTERIAL CARBOXYPEPTIDASE CPG2 VARIANTS AND THEIR USE IN GENE DIRECTED ENZYME PRODRUG THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085960    International Application No.:    PCT/GB2001/001988
Publication Date: 15.11.2001 International Filing Date: 04.05.2001
Chapter 2 Demand Filed:    27.11.2001    
IPC:
A61K 47/48 (2006.01), A61K 48/00 (2006.01), C12N 9/48 (2006.01), C12N 15/87 (2006.01)
Applicants: CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED [GB/GB]; 5 Alfred Place London WC1E 7EB (GB) (For All Designated States Except US).
SPRINGER, Caroline, Joy [GB/GB]; (GB) (For US Only).
MARAIS, Richard, Malcolm [GB/GB]; (GB) (For US Only).
SPOONER, Robert [GB/GB]; (GB) (For US Only)
Inventors: SPRINGER, Caroline, Joy; (GB).
MARAIS, Richard, Malcolm; (GB).
SPOONER, Robert; (GB)
Agent: BRASNETT, Adrian, H.; Mewburn Ellis York House 23 Kingsway London, Greater London WC2B 6HP (GB)
Priority Data:
0011060.1 08.05.2000 GB
Title (EN) BACTERIAL CARBOXYPEPTIDASE CPG2 VARIANTS AND THEIR USE IN GENE DIRECTED ENZYME PRODRUG THERAPY
(FR) VARIANTES DE CARBOXYPEPTIDASES CPG2 BACTERIENNES ET LEUR UTILISATION EN THERAPIE PAR PROMEDICAMENTS CONTENANT UNE ENZYME AYANT UNE ACTION SUR LES GENES
Abstract: front page image
(EN)The present invention relates to bacterial carboxypeptidases for use in gene directed prodrug therapy, in particular for use in the treatment of disease, including tumours. Specifically, the invention relates to modified bacterial carboxypeptidases which have enhanced catalytic activity.
(FR)La présente invention concerne des carboxypeptidases bactériennes destinées à être utilisées en thérapie par promédicaments ayant une action sur les gènes, en particulier pour traiter certaines maladies, notamment les tumeurs. Particulièrement, cette invention concerne des carboxypeptidases bactériennes modifiées présentant une activité catalytique accrue.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)